Farallon Capital Management Llc Buys Aramark, Howmet Aerospace Inc, Macquarie Infrastructure Holdings LLC, Sells , Willis Towers Watson PLC,

• New Purchases: MIC, CTLT, LH, JAZZ, SLGC, CRBU, INFO, IMGO, ABBV, RGEN, BACA.U, MTAL.U, AZN, IPAXU, CVS, DKNG, FIVN, PSTH, PNT, MEAC, SRPT, SHQA, VCYT, CORS, KCGI.U, PSPC, ARYE, CPAR, CMLT, BWCAU, CCXI, NGCA, TNGX,
• Added Positions: ARMK, HWM, TMUS, EFX, NTRA, AVTR, ANTM, NYT, HZNP, WAB, BSX, PACB, RTX, EXAS, CRM, ARWR, FATE, LU, BEAM, BIIB, NVAX, KRTX, RVMD, ZGNX, MA, BBL, NEO, AUS, IOVA, PTGX, SVRA, NXU, YMM,
• Reduced Positions: WLTW, AON, TMO, FIS, MRTX, TRU, GOOG, BABA, FB, MSFT, XLRN, AVGO, IQV, QGEN, CHTR, BCAB, HLT, BX, GPOR, EXEL, ALNY, AMRS, AGIO, SHW, BPMC, ARNA, CNC, NOW, ORTX, BRMK, QSI, ANNX, KVSB, ACHL, GRFS, NUVB, CYTK,
• Sold Out: ALXN, WORK, APLS, ASND, TPTX, RACA, TLND, TGTX, SHQAU, INBX, RCKT, PLRX, PSPC.U, MDLA, ALBO, HIG, CPARU, KRYS, KURA, IMGN, BCTG, FWAA, SRNG, GOSS, TBPH, PHVS, FNCH, CVA,

For the details of FARALLON CAPITAL MANAGEMENT LLC's stock buys and sells, go to https://www.gurufocus.com/guru/farallon+capital+management+llc/current-portfolio/portfolio

1. S&P 500 ETF TRUST ETF (SPY) - 3,756,000 shares, 8.40% of the total portfolio.
2. S&P 500 ETF TRUST ETF (SPY) - 2,700,000 shares, 6.04% of the total portfolio.
3. IQVIA Holdings Inc (IQV) - 2,703,756 shares, 3.38% of the total portfolio. Shares reduced by 5.69%
4. Boston Scientific Corp (BSX) - 14,002,581 shares, 3.17% of the total portfolio. Shares added by 10.11%
5. Aramark (ARMK) - 18,317,656 shares, 3.14% of the total portfolio. Shares added by 50.01%

Farallon Capital Management Llc initiated holding in Macquarie Infrastructure Holdings LLC. The purchase prices were between $38.47 and $40.57, with an estimated average price of $39.48. The stock is now traded at around $3.670000. The impact to a portfolio due to this purchase was 0.92%. The holding were 4,361,050 shares as of 2021-09-30.

Farallon Capital Management Llc initiated holding in Catalent Inc. The purchase prices were between $109.17 and $142.35, with an estimated average price of $124.9. The stock is now traded at around $128.500000. The impact to a portfolio due to this purchase was 0.65%. The holding were 930,199 shares as of 2021-09-30.

Farallon Capital Management Llc initiated holding in Laboratory Corp of America Holdings. The purchase prices were between $274.82 and $308.34, with an estimated average price of $293.32. The stock is now traded at around $286.920000. The impact to a portfolio due to this purchase was 0.52%. The holding were 355,871 shares as of 2021-09-30.

Farallon Capital Management Llc initiated holding in Jazz Pharmaceuticals PLC. The purchase prices were between $128.64 and $184.79, with an estimated average price of $151.34. The stock is now traded at around $139.030000. The impact to a portfolio due to this purchase was 0.39%. The holding were 574,907 shares as of 2021-09-30.

Farallon Capital Management Llc initiated holding in SomaLogic Inc. The purchase prices were between $10.2 and $12.77, with an estimated average price of $11.41. The stock is now traded at around $13.280000. The impact to a portfolio due to this purchase was 0.38%. The holding were 5,826,473 shares as of 2021-09-30.

Farallon Capital Management Llc initiated holding in Caribou Biosciences Inc. The purchase prices were between $15.75 and $30.29, with an estimated average price of $24.56. The stock is now traded at around $21.320000. The impact to a portfolio due to this purchase was 0.37%. The holding were 2,963,448 shares as of 2021-09-30.

Farallon Capital Management Llc added to a holding in Aramark by 50.01%. The purchase prices were between $31.51 and $37.04, with an estimated average price of $34.32. The stock is now traded at around $38.020000. The impact to a portfolio due to this purchase was 1.05%. The holding were 18,317,656 shares as of 2021-09-30.

Farallon Capital Management Llc added to a holding in Howmet Aerospace Inc by 121.33%. The purchase prices were between $30.49 and $34.62, with an estimated average price of $32.21. The stock is now traded at around $32.860000. The impact to a portfolio due to this purchase was 0.93%. The holding were 10,408,000 shares as of 2021-09-30.

Farallon Capital Management Llc added to a holding in T-Mobile US Inc by 33.36%. The purchase prices were between $124.9 and $149.41, with an estimated average price of $139.34. The stock is now traded at around $117.470000. The impact to a portfolio due to this purchase was 0.77%. The holding were 4,599,011 shares as of 2021-09-30.

Farallon Capital Management Llc added to a holding in Equifax Inc by 77.12%. The purchase prices were between $241.17 and $278.28, with an estimated average price of $259.92. The stock is now traded at around $281.300000. The impact to a portfolio due to this purchase was 0.51%. The holding were 891,583 shares as of 2021-09-30.

Farallon Capital Management Llc added to a holding in Natera Inc by 160.03%. The purchase prices were between $100.17 and $126.36, with an estimated average price of $114.79. The stock is now traded at around $113.800000. The impact to a portfolio due to this purchase was 0.47%. The holding were 1,300,134 shares as of 2021-09-30.

Farallon Capital Management Llc added to a holding in Avantor Inc by 150.20%. The purchase prices were between $35.36 and $44.01, with an estimated average price of $39.04. The stock is now traded at around $38.790000. The impact to a portfolio due to this purchase was 0.42%. The holding were 3,265,151 shares as of 2021-09-30.

Farallon Capital Management Llc sold out a holding in . The sale prices were between $179.45 and $186.61, with an estimated average price of $183.84.

Farallon Capital Management Llc sold out a holding in . The sale prices were between $43.97 and $45.2, with an estimated average price of $44.55.

Farallon Capital Management Llc sold out a holding in Apellis Pharmaceuticals Inc. The sale prices were between $31.4 and $69.84, with an estimated average price of $56.51.

Farallon Capital Management Llc sold out a holding in Ascendis Pharma A/S. The sale prices were between $112.67 and $176.92, with an estimated average price of $137.27.

Farallon Capital Management Llc sold out a holding in Turning Point Therapeutics Inc. The sale prices were between $61 and $81.99, with an estimated average price of $71.44.

Farallon Capital Management Llc sold out a holding in Therapeutics Acquisition Corp. The sale prices were between $10.27 and $10.27, with an estimated average price of $10.27.